Skip to main content
DC 5002Musculoskeletal System

Secondary Conditions for Multi-joint arthritis (except post-traumatic and gout), 2 or more joints, as an active process

3 conditions have documented medical links to Multi-joint arthritis (except post-traumatic and gout), 2 or more joints, as an active process. These may qualify as secondary service-connected disabilities if you can establish a medical nexus.

Evidence Strength:STRONGMODERATEEMERGING
STRONG

Medical Rationale

Systemic corticosteroid therapy (prednisone, methylprednisolone, dexamethasone, hydrocortisone) prescribed for service-connected inflammatory or autoimmune conditions causes iatrogenic diabetes mellitus through well-characterized mechanisms. Glucocorticoids induce peripheral insulin resistance by: (1) suppressing GLUT4 glucose transporter translocation in skeletal muscle; (2) increasing hepatic gluconeogenesis by activating key gluconeogenic enzymes (PEPCK, glucose-6-phosphatase); (3) directly inhibiting insulin secretion from pancreatic beta-cells at high doses; and (4) promoting lipolysis with increased free fatty acid delivery to the liver, driving de novo lipogenesis and hepatic glucose output. Studies of patients on systemic corticosteroid therapy document new-onset hyperglycemia in 30–50%, with frank diabetes mellitus in 5–20% depending on dose, duration, and baseline metabolic risk. Steroid-induced diabetes persists after steroid discontinuation in a significant minority of patients.

Key Studies

Clore JN & Thurby-Hay L (2009) Endocr Pract (steroid-induced hyperglycemia); Blackburn D et al. (2002) Diabet Med; Gurwitz JH et al. (1994) Ann Intern Med (glucocorticoids and hyperglycemia); Liu XX et al. (2014) J Endocrinol Invest.

Filing Tips

Prescription records documenting corticosteroid therapy for a service-connected condition. Blood glucose records, HbA1c values, and endocrinology records documenting diabetes onset or significant worsening during corticosteroid use. A nexus letter from your endocrinologist or internist explicitly attributing diabetes development to corticosteroid therapy required for the service-connected condition. Steroid-induced diabetes is legally and medically a direct secondary consequence of treatment for a service-connected condition.

STRONG

Medical Rationale

Rheumatoid arthritis (RA) is a systemic autoimmune disease that produces extra-articular manifestations in 40% of patients, with the lungs being the most common extra-articular target. RA-associated interstitial lung disease (RA-ILD) develops when the same immune dysregulation driving synovial inflammation — autoantibody production (RF, anti-CCP), Th1/Th17 activation, and pro-inflammatory cytokine release (TNF-alpha, IL-6) — targets the pulmonary interstitium. Immune complexes deposit in the alveolar capillary membrane, triggering macrophage activation and fibroblast proliferation that produces progressive pulmonary fibrosis. The usual interstitial pneumonia (UIP) pattern predominates, identical histologically to idiopathic pulmonary fibrosis. RA-ILD develops in 10-30% of RA patients and is the second leading cause of death in RA after cardiovascular disease.

Key Studies

Bongartz T et al. (2010) Arthritis Rheum (RA-associated interstitial lung disease — incidence and mortality); Olson AL et al. (2011) Am J Respir Crit Care Med (RA-ILD prevalence and prognosis).

Filing Tips

High-resolution chest CT demonstrating interstitial lung disease pattern (ground-glass opacities, honeycombing, traction bronchiectasis). Pulmonary function tests showing restrictive pattern with reduced DLCO. Rheumatology and pulmonology records documenting RA diagnosis preceding ILD. Rheumatology nexus letter addressing systemic autoimmune mechanism. If methotrexate is used for RA, the nexus letter should address whether ILD is disease-related or medication-related (both are valid secondary pathways). File under DC 6825 (diffuse interstitial fibrosis) — severe ILD with DLCO <40% predicted can warrant 100% rating.

STRONG

Medical Rationale

Glucocorticoid-induced osteoporosis (GIOP) is the most common form of secondary osteoporosis and a direct consequence of long-term corticosteroid therapy. Mechanisms: glucocorticoids suppress osteoblast differentiation and proliferation (reducing bone formation) while promoting osteoclast lifespan (increasing bone resorption); suppress intestinal calcium absorption and increase renal calcium excretion (producing secondary hyperparathyroidism); directly suppress gonadal hormone production (reducing protective estrogen and testosterone); and promote skeletal muscle wasting, increasing fall risk. Vertebral fracture risk increases 2.6-fold within 3 months of corticosteroid initiation at doses ≥5 mg/day prednisone equivalent. Avascular necrosis (osteonecrosis) of the femoral head is a devastating direct complication of corticosteroid use, occurring in 3–30% of long-term steroid users through fat embolism to the femoral head microvasculature and direct adipocyte hypertrophy causing intraosseous pressure necrosis.

Key Studies

van Staa TP et al. (2000) J Bone Miner Res (glucocorticoids and fracture risk); Saag KG et al. (1998) N Engl J Med (GIOP therapy); Mankin HJ (1992) J Bone Joint Surg Am (avascular necrosis); Assouline-Dayan Y et al. (2002) Semin Arthritis Rheum.

Filing Tips

DEXA scan documenting osteoporosis (T-score ≤ -2.5) or osteopenia with fracture history. MRI of the femoral head (most sensitive test) or plain X-ray (late-stage) documenting avascular necrosis. Prescription records linking long-term corticosteroid use to a service-connected condition. A nexus letter from your rheumatologist, endocrinologist, or orthopedic surgeon connecting the steroid regimen to bone loss and/or AVN. Avascular necrosis requiring hip replacement is particularly debilitating and warrants a separate high-rating secondary claim.

← Back to Multi-joint arthritis (except post-traumatic and gout), 2 or more joints, as an active process rating criteria

Find All Secondary Conditions for Your Situation

AIDEN can analyze your complete medical history and identify secondary conditions specific to your case, including connections that may not appear in standard databases.

Discover Your Secondary Conditions